Ginkgo biloba and acetazolamide for acute mountain sickness: Exclusion of high risk, low status groups perpetuates discrimination and inequalities
AUTOR(ES)
Adams, Jean
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=478272Documentos Relacionados
- Ginkgo biloba and acetazolamide for acute mountain sickness: Authors' reply
- Ginkgo biloba and acetazolamide for acute mountain sickness: Bias in participants may underestimate effectiveness of agents
- Acetazolamide is better than ginkgo biloba for mountain sickness
- Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT)
- Acetazolamide in acute mountain sickness.